OBJECTIVES: Serrated polyposis (hyperplastic polyposis) is characterized by multiple polyps with serrated architecture in the colorectum. Although patients with serrated polyposis are known to be at increased risk of colorectal cancer (CRC) and possibly extracolonic cancers, cancer risk for their relatives has not been widely explored. The aim of this study was to estimate the risks of CRC and extracolonic cancers for relatives of patients with serrated polyposis. METHODS: A cohort of the 1,639 first- and second-degree relatives of 100 index patients with serrated polyposis recruited regardless of a family history of polyps or cancer from genetic clinics in Australia, New Zealand, Canada, and the USA, were retrospectively analyzed to estimate the country-, age-, and sex-specific standardized incidence ratios (SIRs) for relatives compared with the general population. RESULTS: A total of 102 CRCs were observed in first- and second-relatives (SIR 2.25, 95% confidence interval (CI) 1.75-2.93; P<0.001), with 54 in first-degree relatives (SIR 5.16, 95% CI 3.70-7.30; P<0.001) and 48 in second-degree relatives (SIR 1.38, 95% CI 1.01-1.91; P=0.04). Six pancreatic cancers were observed in first-degree relatives (SIR 3.64, 95% CI 1.70-9.21; P=0.003). There was no statistical evidence of increased risk for cancer of the stomach, brain, breast, or prostate. CONCLUSIONS: Our finding that relatives of serrated polyposis patients are at significantly increased risk of colorectal and pancreatic cancer adds to the accumulating evidence that serrated polyposis has an inherited component.
OBJECTIVES: Serrated polyposis (hyperplastic polyposis) is characterized by multiple polyps with serrated architecture in the colorectum. Although patients with serrated polyposis are known to be at increased risk of colorectal cancer (CRC) and possibly extracolonic cancers, cancer risk for their relatives has not been widely explored. The aim of this study was to estimate the risks of CRC and extracolonic cancers for relatives of patients with serrated polyposis. METHODS: A cohort of the 1,639 first- and second-degree relatives of 100 index patients with serrated polyposis recruited regardless of a family history of polyps or cancer from genetic clinics in Australia, New Zealand, Canada, and the USA, were retrospectively analyzed to estimate the country-, age-, and sex-specific standardized incidence ratios (SIRs) for relatives compared with the general population. RESULTS: A total of 102 CRCs were observed in first- and second-relatives (SIR 2.25, 95% confidence interval (CI) 1.75-2.93; P<0.001), with 54 in first-degree relatives (SIR 5.16, 95% CI 3.70-7.30; P<0.001) and 48 in second-degree relatives (SIR 1.38, 95% CI 1.01-1.91; P=0.04). Six pancreatic cancers were observed in first-degree relatives (SIR 3.64, 95% CI 1.70-9.21; P=0.003). There was no statistical evidence of increased risk for cancer of the stomach, brain, breast, or prostate. CONCLUSIONS: Our finding that relatives of serrated polyposispatients are at significantly increased risk of colorectal and pancreatic cancer adds to the accumulating evidence that serrated polyposis has an inherited component.
Authors: Aung Ko Win; Sean P Cleary; James G Dowty; John A Baron; Joanne P Young; Daniel D Buchanan; Melissa C Southey; Terrilea Burnett; Patrick S Parfrey; Roger C Green; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins Journal: Int J Cancer Date: 2011-04-08 Impact factor: 7.396
Authors: Matthew F Kalady; Awad Jarrar; Brandie Leach; Lisa LaGuardia; Margaret O'Malley; Charis Eng; James M Church Journal: Dis Colon Rectum Date: 2011-02 Impact factor: 4.585
Authors: Barbara-Ann Adelstein; Petra Macaskill; Siew F Chan; Peter H Katelaris; Les Irwig Journal: BMC Gastroenterol Date: 2011-05-30 Impact factor: 3.067
Authors: Joseph Carl Anderson; Priya Rangasamy; Tarun Rustagi; Matthew Myers; Melinda Sanders; Haleh Vaziri; George Wu; John W Birk; Petr Protiva Journal: J Clin Gastroenterol Date: 2011-09 Impact factor: 3.062
Authors: P Lage; M Cravo; R Sousa; P Chaves; M Salazar; R Fonseca; I Claro; A Suspiro; P Rodrigues; H Raposo; P Fidalgo; C Nobre-Leitão Journal: Am J Gastroenterol Date: 2004-09 Impact factor: 10.864
Authors: Marcia Irene Canto; Michael Goggins; Charles J Yeo; Constance Griffin; Jennifer E Axilbund; Kieran Brune; Syed Z Ali; Sanjay Jagannath; Gloria M Petersen; Elliot K Fishman; Steven Piantadosi; Francis M Giardiello; Ralph H Hruban Journal: Clin Gastroenterol Hepatol Date: 2004-07 Impact factor: 11.382
Authors: Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt Journal: Am J Gastroenterol Date: 2015-02-03 Impact factor: 10.864
Authors: Manish K Gala; Yusuke Mizukami; Long P Le; Kentaro Moriichi; Thomas Austin; Masayoshi Yamamoto; Gregory Y Lauwers; Nabeel Bardeesy; Daniel C Chung Journal: Gastroenterology Date: 2014-02 Impact factor: 22.682
Authors: Yark Hazewinkel; Johannes B Reitsma; Fokko M Nagengast; Hans F Vasen; Theo A M van Os; Monique E van Leerdam; Jan-Jacob Koornstra; Evelien Dekker Journal: Fam Cancer Date: 2013-12 Impact factor: 2.375
Authors: Christophe Rosty; Michael D Walsh; Rhiannon J Walters; Mark Clendenning; Sally-Ann Pearson; Mark A Jenkins; Aung Ko Win; John L Hopper; Kevin Sweet; Wendy L Frankel; Melyssa Aronson; Steve Gallinger; Jack Goldblatt; Kathy Tucker; Sian Greening; Michael R Gattas; Sonja Woodall; Julie Arnold; Neal I Walker; Susan Parry; Joanne P Young; Daniel D Buchanan Journal: Am J Surg Pathol Date: 2013-03 Impact factor: 6.394